BioLineRx (BLRX) Return on Capital Employed Growth (5y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | BioLineRx | 9.32 Bn | 9.30 Bn | 154,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2,721.00 |
| Sep 30, 2025 | 2,715.00 |
| Jun 30, 2025 | 2,222.00 |
| Mar 31, 2025 | 994.00 |
| Dec 31, 2024 | -236.00 |
| Sep 30, 2024 | -5,051.00 |
| Jun 30, 2024 | -10,551.00 |
| Mar 31, 2024 | -12,737.00 |
| Dec 31, 2023 | -26,097.00 |
| Sep 30, 2023 | -3,685.00 |
| Jun 30, 2023 | -1,117.00 |
| Mar 31, 2023 | -205.00 |
| Dec 31, 2022 | 176.00 |
| Sep 30, 2022 | -392.00 |
| Jun 30, 2022 | -146.00 |
| Mar 31, 2022 | 1,492.00 |
| Dec 31, 2021 | 1,141.00 |
| Sep 30, 2021 | 944.00 |
| Jun 30, 2021 | 549.00 |
| Mar 31, 2021 | -610.00 |
| Dec 31, 2020 | -3,127.00 |
| Sep 30, 2020 | -3,524.00 |
| Jun 30, 2020 | -4,189.00 |
| Mar 31, 2020 | -3,621.00 |
| Dec 31, 2019 | -841.00 |
| Sep 30, 2019 | -468.00 |
| Jun 30, 2019 | -553.00 |
| Mar 31, 2019 | 844.00 |
| Dec 31, 2018 | 3,468.00 |